Deutsche Bank’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,094
Closed -$435K 4092
2022
Q4
$435K Buy
12,094
+1,015
+9% +$25.4K ﹤0.01% 2521
2022
Q3
$167K Sell
11,079
-1,760
-14% -$28.5K ﹤0.01% 3050
2022
Q2
$172K Buy
12,839
+1,278
+11% +$20.3K ﹤0.01% 3255
2022
Q1
$223K Buy
11,561
+5,653
+96% +$117K ﹤0.01% 3203
2021
Q4
$140K Buy
5,908
+302
+5% +$7K ﹤0.01% 3553
2021
Q3
$112K Buy
+5,606
New +$120K ﹤0.01% 3856

Deutsche Bank's IMGO Position: Q1 2023 in Review

Deutsche Bank sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 12,094 shares — an estimated $435K sold.

Deutsche Bank first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $435K in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Deutsche Bank reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Deutsche Bank sold 12,094 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $435K.
  • Deutsche Bank first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
  • Deutsche Bank's Imago BioSciences, Inc. Common stock position peaked at $435K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Deutsche Bank's 13F filing for Q1 2023, filed 15 May 2023.